BETHESDA, MD 07 October 2013—In a
customer communication (PDF) dated October 4, Hospira announced the nationwide
recall of a single lot of lidocaine hydrochloride injection that may contain
According to Hospira, the company has confirmed the
presence of reddish-black oxidized stainless steel particles inside a 20-mL flip-top
vial of 1% lidocaine hydrochloride injection, lot 25-090-DK. The lot number on vials
in this lot may be followed by the numerals 01 or 02, the company stated.
The vials were distributed March through June of
Hospira is working to identify the root cause of
the problem, the company stated.
Anyone with the recalled lot in stock should
quarantine the vials and contact Stericycle at 866-364-8812 from 8:00 am to 5:00
pm Eastern Time, Monday through Friday, for return and replacement of the
For questions, comments, or
more information on this
article, please contact the
ASHP News Center at email@example.com.
Stay connected with ASHP through our social media tools.
What We Do
For the Press
Jobs at ASHP
AHFS Drug Information
Customer Service: 1-866-279-0681
8:00am - 6:00pm ET, Mon-Fri
American Society of Health-System Pharmacists. All rights reserved. 7272 Wisconsin Avenue, Bethesda, MD 20814